Product Code: TMRGL47583
Veterinary Supplements Market - Scope of Report
TMR's report on the global veterinary supplements market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global veterinary supplements market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global veterinary supplements market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the veterinary supplements market.
Market Snapshot |
Market Value in 2023 | US$ 8.3 Bn |
Market Value in 2031 | US$ 15.2 Bn |
CAGR | 6.9% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global veterinary supplements market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global veterinary supplements market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary supplements market.
The report delves into the competitive landscape of the global veterinary supplements market. Key players operating in the global veterinary supplements market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global veterinary supplements market profiled in this report.
Key Questions Answered in Global Veterinary Supplements Market Report:
- What is the sales/revenue generated by veterinary supplements across all regions during the forecast period?
- What are the opportunities in the global veterinary supplements market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Veterinary Supplements Market - Research Objectives and Research Approach
The comprehensive report on the global veterinary supplements market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global veterinary supplements market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global veterinary supplements market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Veterinary Supplements Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Supplement Type Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Veterinary Supplements Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Insights on The impact of e-commerce on the pet sales landscape
- 5.2. U.S. pet ownership statistics
- 5.3. Regulatory Scenario by Region/Globally
- 5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Veterinary Supplements Market Analysis and Forecast, by Supplement Type
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Supplement Type, 2017-2031
- 6.3.1. Antioxidants
- 6.3.2. Vitamins
- 6.3.3. Proteins/Amino acids
- 6.3.4. Enzymes
- 6.3.5. Probiotics
- 6.3.6. Essential Fatty Acids
- 6.3.7. Others
- 6.4. Market Attractiveness Analysis, by Supplement Type
7. Global Veterinary Supplements Market Analysis and Forecast, by Animal Type
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Animal Type, 2017-2031
- 7.3.1. Companion Animals
- 7.3.1.1. Dog
- 7.3.1.2. Cat
- 7.3.2. Livestock
- 7.3.2.1. Cattle
- 7.3.2.2. Horse
- 7.3.2.3. Sheep
- 7.3.3. Others
- 7.4. Market Attractiveness Analysis, by Animal Type
8. Global Veterinary Supplements Market Analysis and Forecast, by Application/Benefit Area
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by Application/Benefit Area, 2017-2031
- 8.3.1. Joint Health Support
- 8.3.2. Calming/Stress/Anxiety
- 8.3.3. Digestive Health
- 8.3.4. Energy & Electrolytes
- 8.3.5. Immunity Support
- 8.3.6. Skin & Coat Health
- 8.3.7. Others
- 8.4. Market Attractiveness Analysis, by Application/Benefit Area
9. Global Veterinary Supplements Market Analysis and Forecast, by Dosage Form
- 9.1. Introduction & Definition
- 9.2. Key Findings/Developments
- 9.3. Market Value Forecast, by Dosage Form, 2017-2031
- 9.3.1. Pills & Tablets
- 9.3.2. Chewables
- 9.3.3. Powders
- 9.3.4. Others
- 9.4. Market Attractiveness Analysis, by Dosage Form
10. Global Veterinary Supplements Market Analysis and Forecast, by Distribution Channel
- 10.1. Introduction & Definition
- 10.2. Key Findings/Developments
- 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 10.3.1. Small Animal Veterinary
- 10.3.2. Large Animal Veterinary
- 10.3.3. Mixed Animal Veterinary
- 10.3.4. Retail Stores
- 10.3.5. Drug Stores
- 10.3.6. Online Sales
- 10.4. Market Attractiveness Analysis, by Distribution Channel
11. Global Veterinary Supplements Market Analysis and Forecast, by Region
- 11.1. Key Findings
- 11.2. Market Value Forecast, by Region, 2017-2031
- 11.2.1. North America
- 11.2.2. Europe
- 11.2.3. Asia Pacific
- 11.2.4. Latin America
- 11.2.5. Middle East & Africa
- 11.3. Market Attractiveness Analysis, by Region
12. North America Veterinary Supplements Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Supplement Type, 2017-2031
- 12.2.1. Antioxidants
- 12.2.2. Vitamins
- 12.2.3. Proteins/Amino acids
- 12.2.4. Enzymes
- 12.2.5. Probiotics
- 12.2.6. Essential Fatty Acids
- 12.2.7. Others
- 12.3. Market Value Forecast, by Animal Type, 2017-2031
- 12.3.1. Companion Animals
- 12.3.1.1. Dog
- 12.3.1.2. Cat
- 12.3.2. Livestock
- 12.3.2.1. Cattle
- 12.3.2.2. Horse
- 12.3.2.3. Sheep
- 12.3.3. Others
- 12.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
- 12.4.1. Joint Health Support
- 12.4.2. Calming/Stress/Anxiety
- 12.4.3. Digestive Health
- 12.4.4. Energy & Electrolytes
- 12.4.5. Immunity Support
- 12.4.6. Skin & Coat Health
- 12.4.7. Others
- 12.5. Market Value Forecast, by Dosage Form, 2017-2031
- 12.5.1. Pills & Tablets
- 12.5.2. Chewables
- 12.5.3. Powders
- 12.5.4. Others
- 12.6. Market Value Forecast, by Distribution Channel, 2017-2031
- 12.6.1. Small Animal Veterinary
- 12.6.2. Large Animal Veterinary
- 12.6.3. Mixed Animal Veterinary
- 12.6.4. Retail Stores
- 12.6.5. Drug Stores
- 12.6.6. Online Sales
- 12.7. Market Value Forecast, by Country, 2017-2031
- 12.7.1. U.S.
- 12.7.2. Canada
- 12.8. Market Attractiveness Analysis
- 12.8.1. By Supplement Type
- 12.8.2. By Animal Type
- 12.8.3. By Application/Benefit Area
- 12.8.4. By Dosage Form
- 12.8.5. By Distribution Channel
- 12.8.6. By Country
13. Europe Veterinary Supplements Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Supplement Type, 2017-2031
- 13.2.1. Antioxidants
- 13.2.2. Vitamins
- 13.2.3. Proteins/Amino acids
- 13.2.4. Enzymes
- 13.2.5. Probiotics
- 13.2.6. Essential Fatty Acids
- 13.2.7. Others
- 13.3. Market Value Forecast, by Animal Type, 2017-2031
- 13.3.1. Companion Animals
- 13.3.1.1. Dog
- 13.3.1.2. Cat
- 13.3.2. Livestock
- 13.3.2.1. Cattle
- 13.3.2.2. Horse
- 13.3.2.3. Sheep
- 13.3.3. Others
- 13.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
- 13.4.1. Joint Health Support
- 13.4.2. Calming/Stress/Anxiety
- 13.4.3. Digestive Health
- 13.4.4. Energy & Electrolytes
- 13.4.5. Immunity Support
- 13.4.6. Skin & Coat Health
- 13.4.7. Others
- 13.5. Market Value Forecast, by Dosage Form, 2017-2031
- 13.5.1. Pills & Tablets
- 13.5.2. Chewables
- 13.5.3. Powders
- 13.5.4. Others
- 13.6. Market Value Forecast, by Distribution Channel, 2017-2031
- 13.6.1. Small Animal Veterinary
- 13.6.2. Large Animal Veterinary
- 13.6.3. Mixed Animal Veterinary
- 13.6.4. Retail Stores
- 13.6.5. Drug Stores
- 13.6.6. Online Sales
- 13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.7.1. Germany
- 13.7.2. U.K.
- 13.7.3. France
- 13.7.4. Italy
- 13.7.5. Spain
- 13.7.6. Rest of Europe
- 13.8. Market Attractiveness Analysis
- 13.8.1. By Supplement Type
- 13.8.2. By Animal Type
- 13.8.3. By Application/Benefit Area
- 13.8.4. By Dosage Form
- 13.8.5. By Distribution Channel
- 13.8.6. By Country/Sub-region
14. Asia Pacific Veterinary Supplements Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Supplement Type, 2017-2031
- 14.2.1. Antioxidants
- 14.2.2. Vitamins
- 14.2.3. Proteins/Amino acids
- 14.2.4. Enzymes
- 14.2.5. Probiotics
- 14.2.6. Essential Fatty Acids
- 14.2.7. Others
- 14.3. Market Value Forecast, by Animal Type, 2017-2031
- 14.3.1. Companion Animals
- 14.3.1.1. Dog
- 14.3.1.2. Cat
- 14.3.2. Livestock
- 14.3.2.1. Cattle
- 14.3.2.2. Horse
- 14.3.2.3. Sheep
- 14.3.3. Others
- 14.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
- 14.4.1. Joint Health Support
- 14.4.2. Calming/Stress/Anxiety
- 14.4.3. Digestive Health
- 14.4.4. Energy & Electrolytes
- 14.4.5. Immunity Support
- 14.4.6. Skin & Coat Health
- 14.4.7. Others
- 14.5. Market Value Forecast, by Dosage Form, 2017-2031
- 14.5.1. Pills & Tablets
- 14.5.2. Chewables
- 14.5.3. Powders
- 14.5.4. Others
- 14.6. Market Value Forecast, by Distribution Channel, 2017-2031
- 14.6.1. Small Animal Veterinary
- 14.6.2. Large Animal Veterinary
- 14.6.3. Mixed Animal Veterinary
- 14.6.4. Retail Stores
- 14.6.5. Drug Stores
- 14.6.6. Online Sales
- 14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.7.1. China
- 14.7.2. Japan
- 14.7.3. India
- 14.7.4. Australia & New Zealand
- 14.7.5. Rest of Asia Pacific
- 14.8. Market Attractiveness Analysis
- 14.8.1. By Supplement Type
- 14.8.2. By Animal Type
- 14.8.3. By Application/Benefit Area
- 14.8.4. By Dosage Form
- 14.8.5. By Distribution Channel
- 14.8.6. By Country/Sub-region
15. Latin America Veterinary Supplements Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Supplement Type, 2017-2031
- 15.2.1. Antioxidants
- 15.2.2. Vitamins
- 15.2.3. Proteins/Amino acids
- 15.2.4. Enzymes
- 15.2.5. Probiotics
- 15.2.6. Essential Fatty Acids
- 15.2.7. Others
- 15.3. Market Value Forecast, by Animal Type, 2017-2031
- 15.3.1. Companion Animals
- 15.3.1.1. Dog
- 15.3.1.2. Cat
- 15.3.2. Livestock
- 15.3.2.1. Cattle
- 15.3.2.2. Horse
- 15.3.2.3. Sheep
- 15.3.3. Others
- 15.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
- 15.4.1. Joint Health Support
- 15.4.2. Calming/Stress/Anxiety
- 15.4.3. Digestive Health
- 15.4.4. Energy & Electrolytes
- 15.4.5. Immunity Support
- 15.4.6. Skin & Coat Health
- 15.4.7. Others
- 15.5. Market Value Forecast, by Dosage Form, 2017-2031
- 15.5.1. Pills & Tablets
- 15.5.2. Chewables
- 15.5.3. Powders
- 15.5.4. Others
- 15.6. Market Value Forecast, by Distribution Channel, 2017-2031
- 15.6.1. Small Animal Veterinary
- 15.6.2. Large Animal Veterinary
- 15.6.3. Mixed Animal Veterinary
- 15.6.4. Retail Stores
- 15.6.5. Drug Stores
- 15.6.6. Online Sales
- 15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.7.1. Brazil
- 15.7.2. Mexico
- 15.7.3. Rest of Latin America
- 15.8. Market Attractiveness Analysis
- 15.8.1. By Supplement Type
- 15.8.2. By Animal Type
- 15.8.3. By Application/Benefit Area
- 15.8.4. By Dosage Form
- 15.8.5. By Distribution Channel
- 15.8.6. By Country/Sub-region
16. Middle East & Africa Veterinary Supplements Market Analysis and Forecast
- 16.1. Introduction
- 16.2. Market Value Forecast, by Supplement Type, 2017-2031
- 16.2.1. Antioxidants
- 16.2.2. Vitamins
- 16.2.3. Proteins/Amino acids
- 16.2.4. Enzymes
- 16.2.5. Probiotics
- 16.2.6. Essential Fatty Acids
- 16.2.7. Others
- 16.3. Market Value Forecast, by Animal Type, 2017-2031
- 16.3.1. Companion Animals
- 16.3.1.1. Dog
- 16.3.1.2. Cat
- 16.3.2. Livestock
- 16.3.2.1. Cattle
- 16.3.2.2. Horse
- 16.3.2.3. Sheep
- 16.3.3. Others
- 16.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
- 16.4.1. Joint Health Support
- 16.4.2. Calming/Stress/Anxiety
- 16.4.3. Digestive Health
- 16.4.4. Energy & Electrolytes
- 16.4.5. Immunity Support
- 16.4.6. Skin & Coat Health
- 16.4.7. Others
- 16.5. Market Value Forecast, by Dosage Form, 2017-2031
- 16.5.1. Pills & Tablets
- 16.5.2. Chewables
- 16.5.3. Powders
- 16.5.4. Others
- 16.6. Market Value Forecast, by Distribution Channel, 2017-2031
- 16.6.1. Small Animal Veterinary
- 16.6.2. Large Animal Veterinary
- 16.6.3. Mixed Animal Veterinary
- 16.6.4. Retail Stores
- 16.6.5. Drug Stores
- 16.6.6. Online Sales
- 16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
- 16.7.1. GCC Countries
- 16.7.2. South Africa
- 16.7.3. Rest of Middle East & Africa
- 16.8. Market Attractiveness Analysis
- 16.8.1. By Supplement Type
- 16.8.2. By Animal Type
- 16.8.3. By Application/Benefit Area
- 16.8.4. By Dosage Form
- 16.8.5. By Distribution Channel
- 16.8.6. By Country/Sub-region
17. Competition Landscape
- 17.1. Market Player - Competition Matrix (by tier and size of companies)
- 17.2. Market Share Analysis, by Company, 2022
- 17.3. Company Profiles
- 17.3.1. Zoetis
- 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.1.2. Product Portfolio
- 17.3.1.3. Financial Overview
- 17.3.1.4. SWOT Analysis
- 17.3.1.5. Strategic Overview
- 17.3.2. Ceva Sante Animale
- 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.2.2. Product Portfolio
- 17.3.2.3. Financial Overview
- 17.3.2.4. SWOT Analysis
- 17.3.2.5. Strategic Overview
- 17.3.3. Elanco Animal Health
- 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.3.2. Product Portfolio
- 17.3.3.3. Financial Overview
- 17.3.3.4. SWOT Analysis
- 17.3.3.5. Strategic Overview
- 17.3.4. Vetoquinol S.A.
- 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.4.2. Product Portfolio
- 17.3.4.3. Financial Overview
- 17.3.4.4. SWOT Analysis
- 17.3.4.5. Strategic Overview
- 17.3.5. Dechra Pharmaceuticals plc
- 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.5.2. Product Portfolio
- 17.3.5.3. Financial Overview
- 17.3.5.4. SWOT Analysis
- 17.3.5.5. Strategic Overview
- 17.3.6. Merck Animal Health
- 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.6.2. Product Portfolio
- 17.3.6.3. Financial Overview
- 17.3.6.4. SWOT Analysis
- 17.3.6.5. Strategic Overview
- 17.3.7. Virbac S.A.
- 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.7.2. Product Portfolio
- 17.3.7.3. Financial Overview
- 17.3.7.4. SWOT Analysis
- 17.3.7.5. Strategic Overview
- 17.3.8. Boehringer Ingelheim
- 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.8.2. Product Portfolio
- 17.3.8.3. Financial Overview
- 17.3.8.4. SWOT Analysis
- 17.3.8.5. Strategic Overview
- 17.3.9. Norbrook Laboratories Limited
- 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.9.2. Product Portfolio
- 17.3.9.3. Financial Overview
- 17.3.9.4. SWOT Analysis
- 17.3.9.5. Strategic Overview
- 17.3.10. Hester Biosciences Limited
- 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.10.2. Product Portfolio
- 17.3.10.3. Financial Overview
- 17.3.10.4. SWOT Analysis
- 17.3.10.5. Strategic Overview
- 17.3.11. Merial Animal Health Limited
- 17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.11.2. Product Portfolio
- 17.3.11.3. Financial Overview
- 17.3.11.4. SWOT Analysis
- 17.3.11.5. Strategic Overview
- 17.3.12. Novartis Animal Health, Inc.
- 17.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.12.2. Product Portfolio
- 17.3.12.3. Financial Overview
- 17.3.12.4. SWOT Analysis
- 17.3.12.5. Strategic Overview
- 17.3.13. Nutreco N.V.
- 17.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.13.2. Product Portfolio
- 17.3.13.3. Financial Overview
- 17.3.13.4. SWOT Analysis
- 17.3.13.5. Strategic Overview
- 17.3.14. Ouro Fino Saude Animal
- 17.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.14.2. Product Portfolio
- 17.3.14.3. Financial Overview
- 17.3.14.4. SWOT Analysis
- 17.3.14.5. Strategic Overview